Dear colleagues,
The Johns Hopkins University School of Medicine invites applications for postdoctoral research fellowships at the Behavioral Pharmacology Research Unit (BPRU) within the Department of Psychiatry and Behavioral Sciences. Fellows receive research training in the clinical pharmacology of substance use including human laboratory studies and clinical treatment trials. Fellows benefit from experienced faculty and a NIDA-funded T32 training grant with a productive 40-year history and over 130 graduates. Fellows work closely with faculty mentors to gain practical research experience and develop as productive independent scholars.
Areas of interest: This postdoctoral fellow will work with Drs Kelly Dunn and Andrew Huhn in the area of opioid use disorder. Fellows will have the opportunity to gain experience in clinical trials, human laboratory drug administration studies, and treatment outcomes studies. Research in the Dunn and Huhn labs cover a broad range of topics, including the treatment of opioid use disorder, opioid withdrawal, sleep, emotional processes, chronic and acute pain, and abuse liability of opioids and other medications. These studies employ diverse methodology including ecological momentary assessments, sleep electroencephalography (EEG), ambulatory monitoring of daily activity and sleep, quantitative sensory testing of pain, genetics, and biological assays of stress and inflammation. Prospective candidates should have a strong interest in medication studies and/or utilizing advanced statistical analyses (e.g., machine learning). The selected candidate would also have the opportunity to collaborate with multiple BPRU faculty across different projects.
Eligibility: Eligible applicants must be a U.S. citizen or permanent resident and have completed doctoral degree requirements (e.g., PhD, MD, DO, PsyD) prior to starting at BPRU. Many backgrounds are appropriate, including experimental or clinical psychology, pharmacology, psychiatry or other medicine, neuroscience, nursing, public health, and social work. Prior experience with human or nonhuman research is appropriate. The BPRU is particularly interested in candidates who can contribute to the diversity and excellence of our research program. Applications from persons with disabilities, protected veterans, and persons underrepresented in science are strongly encouraged.
Start date: Flexible.
To Apply please send your CV and letter of interest to Kelly E. Dunn, Ph.D, MBA (kdunn9@jhmi.edu) and Andrew S. Huhn, Ph.D., MBA (ahuhn1@jhmi.edu)
Areas of interest: This postdoctoral fellow will work with Drs Kelly Dunn and Andrew Huhn in the area of opioid use disorder. Fellows will have the opportunity to gain experience in clinical trials, human laboratory drug administration studies, and treatment outcomes studies. Research in the Dunn and Huhn labs cover a broad range of topics, including the treatment of opioid use disorder, opioid withdrawal, sleep, emotional processes, chronic and acute pain, and abuse liability of opioids and other medications. These studies employ diverse methodology including ecological momentary assessments, sleep electroencephalography (EEG), ambulatory monitoring of daily activity and sleep, quantitative sensory testing of pain, genetics, and biological assays of stress and inflammation. Prospective candidates should have a strong interest in medication studies and/or utilizing advanced statistical analyses (e.g., machine learning). The selected candidate would also have the opportunity to collaborate with multiple BPRU faculty across different projects.
Eligibility: Eligible applicants must be a U.S. citizen or permanent resident and have completed doctoral degree requirements (e.g., PhD, MD, DO, PsyD) prior to starting at BPRU. Many backgrounds are appropriate, including experimental or clinical psychology, pharmacology, psychiatry or other medicine, neuroscience, nursing, public health, and social work. Prior experience with human or nonhuman research is appropriate. The BPRU is particularly interested in candidates who can contribute to the diversity and excellence of our research program. Applications from persons with disabilities, protected veterans, and persons underrepresented in science are strongly encouraged.
Start date: Flexible.
To Apply please send your CV and letter of interest to Kelly E. Dunn, Ph.D, MBA (kdunn9@jhmi.edu) and Andrew S. Huhn, Ph.D., MBA (ahuhn1@jhmi.edu)
Faculty: https://www.hopkinsmedicine.org/psychiatry/research/BPRU/expert_team.html and Program Website: https://www.hopkinsmedicine.org/psychiatry/research/BPRU/
Johns Hopkins University is an equal opportunity/affirmative action employer committed to recruiting, supporting, and fostering a diverse community.
Johns Hopkins University is an equal opportunity/affirmative action employer committed to recruiting, supporting, and fostering a diverse community.
---
Kelly Dunn, Ph.D., M.B.A.
Kelly Dunn, Ph.D., M.B.A.
President, Division on Psychopharmacology and Substance Use (Division 28)
American Psychological Association
Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030
No comments:
Post a Comment